Market News

DAVIDsTEA Inc. (DTEA) Reaches $4.10 After 5.00% Up Move; Eden Bioscience (EDEN) Has 0.58 Sentiment

The ETF decreased 0.05% or $0.03 during the last trading session, reaching $65.92. About 26,158 shares traded or 24.05% up from the average. iShares MSCI Denmark Capped ETF (EDEN) has risen 8.76% since December 13, 2016 and is uptrending. It has underperformed by 7.94% the S&P500.

The stock of DAVIDsTEA Inc. (NASDAQ:DTEA) is a huge mover today! The stock increased 5.13% or $0.2 during the last trading session, reaching $4.1. About 125,194 shares traded or 145.93% up from the average. DAVIDsTEA Inc. (NASDAQ:DTEA) has declined 44.49% since December 13, 2016 and is downtrending. It has underperformed by 61.19% the S&P500.The move comes after 9 months positive chart setup for the $105.96M company. It was reported on Dec, 13 by Barchart.com. We have $4.31 PT which if reached, will make NASDAQ:DTEA worth $5.30 million more.

Analysts await DAVIDsTEA Inc. (NASDAQ:DTEA) to report earnings on December, 14. They expect $-0.15 earnings per share, down 114.29% or $0.08 from last year’s $-0.07 per share. After $-0.12 actual earnings per share reported by DAVIDsTEA Inc. for the previous quarter, Wall Street now forecasts 25.00% negative EPS growth.

Among 3 analysts covering DAVIDsTEA Inc (NASDAQ:DTEA), 0 have Buy rating, 1 Sell and 2 Hold. Therefore 0 are positive. DAVIDsTEA Inc has $16 highest and $5.5 lowest target. $11.50’s average target is 180.49% above currents $4.1 stock price. DAVIDsTEA Inc had 8 analyst reports since September 10, 2015 according to SRatingsIntel. William Blair downgraded DAVIDsTEA Inc. (NASDAQ:DTEA) on Friday, December 9 to “Market Perform” rating. The firm earned “Market Perform” rating on Friday, December 9 by BMO Capital Markets. On Wednesday, June 7 the stock rating was maintained by BMO Capital Markets with “Hold”. The stock of DAVIDsTEA Inc. (NASDAQ:DTEA) earned “Underperform” rating by Bank of America on Tuesday, December 13. BMO Capital Markets maintained it with “Hold” rating and $5.5 target in Thursday, September 7 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *